Cencora, Inc. (BIT:1COR)

Market Cap	61.65B
Revenue (ttm)	273.87B
Net Income (ttm)	1.32B
Shares Out	n/a
EPS (ttm)	6.78
PE Ratio	46.54
Forward PE	20.72
Dividend	1.56 (0.50%)
Ex-Dividend Date	Nov 13, 2025

Volume	n/a
Average Volume	5
Open	311.30
Previous Close	311.30
Day's Range	311.30 - 311.30
52-Week Range	237.46 - 315.38
Beta	n/a
RSI	47.13
Earnings Date	Nov 5, 2025

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1COR

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD